BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24501004)

  • 1. Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?
    Tachezy M; Zander H; Wolters-Eisfeld G; Müller J; Wicklein D; Gebauer F; Izbicki JR; Bockhorn M
    Stem Cells; 2014 Jun; 32(6):1429-36. PubMed ID: 24501004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
    Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
    J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
    Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
    Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
    Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
    Minner S; Kraetzig F; Tachezy M; Kilic E; Graefen M; Wilczak W; Bokemeyer C; Huland H; Sauter G; Schlomm T
    Hum Pathol; 2011 Dec; 42(12):1946-52. PubMed ID: 21683980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
    Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
    Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
    Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
    J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
    Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
    BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
    Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
    J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway.
    Jiang Z; Zhang J; Chen F; Sun Y
    Thorac Cancer; 2020 Feb; 11(2):415-425. PubMed ID: 31883226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
    Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
    Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
    Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
    Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
    Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
    Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
    Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer.
    Xiao M; Yan M; Zhang J; Xu Q; Qi S; Wang X; Chen W
    Exp Cell Res; 2017 Apr; 353(1):46-53. PubMed ID: 28279658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.